Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Rs 17 Crores Drugs...

    Rs 17 Crores Drugs allegedly sold for Rs 77 crores: High Court Fines Dr Reddys Laboratories

    Written by Ruby Khatun Khatun Published On 2017-07-15T16:18:07+05:30  |  Updated On 15 July 2017 4:18 PM IST
    Rs 17 Crores Drugs allegedly sold for Rs 77 crores: High Court Fines Dr Reddys Laboratories

    New Delhi: In a violation of Essential Commodities Act, 1955, Dr Reddy’s has been found selling 11 drugs at a price over and above the maximum fixed by the government.


    Responding to thisDelhi high court on thursday, levied a penalty of Rs 9 lakh on Dr Reddy’s Laboratories for selling 11 drugs-whose names were undisclosed for the offence. Essential Commodities Act, 1955 is an act under which the central government can fix a maximum price ceiling for certain essential commodities in the interests of the general public.


    The counsel for the government argued, “They must follow the price (set by the central government under the provisions of the Essential Commodities Act) for the drugs, out of the total amount of Rs 77 crores, Rs 60 crores is the overcharged amount (amount charged by the Labs on the 11 drugs above the price ceiling).


    Dr. Reddy’s Laboratories contested against the penalty amount imposed and contended that it should amount to Rs 9 lakh only as opposed to Rs 77 crore, as claimed by the government.


    Livemint reports that the court directed the government to give a hearing to Dr. Reddy’s regarding alleged disagreement with respect to computation of the penalty amount. Dr. Reddy’s on their part assured the court that all necessary remedial steps have been taken and it was now complying with the price ceiling and selling the drugs at a price below the ceiling.


    High court ordered Dr. Reddy’s to pay the admitted amount of Rs 9 lakh as penalty and directed the government to deal with issues raised on computation in a hearing to be held on 21 July

    above price ceilingDelhi high courtDr Reddy'sDr Reddy's LaboratoriesDrug overpricingdrugsEssential Commodities ActHigh Courtoverpricingoverpricing Dr Reddy's casepenaltyselling
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok